POLRMT and prostate carcinoma: POLRMT silencing led to significant mitochondrial depolarization and ROS production in the primary/established prostate cancer cells, evidenced by increasing in JC-1 green fluorescence monomer intensity (Fig. 4H) and CellROX red fluorescence intensity increasing (Fig. 4I), respectively.